Update on islet transplantation

Cold Spring Harbor Perspectives in Medicine

Volumn 2, Issue 7, 2012, Pages

  McCall, Michael ^a   James Shapiro, A M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXYSPERGUALIN; AUTOANTIGEN; C PEPTIDE; CD52 ANTIGEN; CYCLOSPORIN; DACLIZUMAB; EFALIZUMAB; ETANERCEPT; GLUCAGON LIKE PEPTIDE 1; HLA ANTIGEN; INFLIXIMAB; INTERLEUKIN 1; INTERLEUKIN 2 RECEPTOR ALPHA; MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; X LINKED INHIBITOR OF APOPTOSIS;

ALLOTRANSPLANTATION; APOPTOSIS; ARTICLE; AUTOIMMUNITY; BILE LEAKAGE; BIOCOMPATIBILITY; DONOR SELECTION; ENGRAFTMENT; GROWTH STIMULATION; HUMAN; HYPOXIA; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENCE; INSULIN DEPENDENT DIABETES MELLITUS; LIVING DONOR; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN DONOR; OXYGEN TENSION; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PORTAL VEIN THROMBOSIS; POSITRON EMISSION TOMOGRAPHY; PRE T LYMPHOCYTE; RANDOMIZED CONTROLLED TRIAL (TOPIC); ANIMAL; DRUG ANTAGONISM; IMMUNOLOGY; INFLAMMATION; METHODOLOGY; NECROSIS; PORTAL VEIN; REVIEW; TRANSPLANTATION;

PLUCHEA CAROLINENSIS;

ANIMALS; APOPTOSIS; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; HUMANS; IMMUNOSUPPRESSION; INFLAMMATION; ISLETS OF LANGERHANS TRANSPLANTATION; NECROSIS; PORTAL SYSTEM; TISSUE AND ORGAN PROCUREMENT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84872778829     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a007823     Document Type: Article

References (96)

1. Ballinger WF, Lacy PE. 1972. Transplantation of intact pancreatic islets in rats. Surgery 72: 175-186.
2. Bennet W, Sundberg B, Groth CG, Brendel MD, Brandhorst D, Brandhorst H, Bretzel RG, Elgue G, Larsson R, Nilsson B, et al. 1999. Incompatibility between human blood and isolated islets of Langerhans: A finding with implications for clinical intraportal islet transplantation? Diabetes 48: 1907-1914.
3. Bennet W, Groth CG, Larsson R, Nilsson B, Korsgren O. 2000. Isolated human islets trigger an instant blood mediated inflammatory reaction: Implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes. Ups J Med Sci 105: 125-133.
4. Berney T, Ferrari-Lacraz S, Buhler L, Oberholzer J, Marangon N, Philippe J, Villard J, Morel P. 2009. Long-term insulin-independence after allogeneic islet transplantation for type 1 diabetes: Over the 10-year mark. Am J Transplant 9: 419-423.
5. Biarnes M, Montolio M, Nacher V, Raurell M, Soler J, Montanya E. 2002. β-cell death and mass in syngeneically transplanted islets exposed to short-and long-term hyperglycemia. Diabetes 51: 66-72.
6. Bluestone JA. 2005. CTLA-4Ig is finally making it: A personal perspective. Am J Transplant 5: 423-424.
7. Brandhorst H, Friberg A, Nilsson B, Andersson HH, Felldin M, Foss A, SalmelaK, Tibell A, Tufveson G, Korsgren O, et al. 2010. Large-scale comparison of Liberase HI and collagenase NB1 utilized for human islet isolation. Cell Transplant 19: 3-8.
8. Burke GW III., Vendrame F, Pileggi A, Ciancio G, Reijonen H, Pugliese A. 2011. Recurrence of autoimmunity following pancreas transplantation. Curr Diab Rep 11: 413-419.
9. Cabric S, Sanchez J, Lundgren T, Foss A, Felldin M, Kallen R, Salmela K, TibellA, Tufveson G, Larsson R, et al. 2007. Islet surface heparinization prevents the instant blood-mediated inflammatory reaction in islet transplantation. Diabetes 56: 2008-2015.
10. Calafiore R, Basta G, Luca G, Lemmi A, Montanucci MP, Calabrese G, Racanicchi L, Mancuso F, Brunetti P. 2006. Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: First two cases. Diabetes Care 29: 137-138.
11. Cantarelli E, Melzi R, Mercalli A, Sordi V, Ferrari G, Lederer CW, Mrak E, Rubinacci A, Ponzoni M, Sitia G, et al. 2009. Bone marrow as an alternative site for islet transplantation. Blood 114: 4566-4574.
12. Chatenoud L. 2008. Chemical immunosuppression in islet transplantation-Friend or foe? N Engl J Med 358: 1192-1193.
13. Chick WL, Perna JJ, Lauris V, Low D, Galletti PM, Panol G, Whittemore AD, LikeAA, Colton CK, Lysaght MJ. 1977. Artificial pancreas using living β cells: Effects on glucose homeostasis in diabetic rats. Science 197: 780-782.
14. Christoffersson G, Henriksnas J, Johansson L, Rolny C, Ahlstrom H, Caballero-Corbalan J, Segersvard R, Permert J, Korsgren O, Carlsson PO, et al. 2010. Clinical and experimental pancreatic islet transplantation to striated muscle: Establishment of a vascular system similar to that in native islets. Diabetes 59: 2569-2578.
15. Duvivier-Kali VF, Omer A, Parent RJ, O'Neil JJ, Weir GC. 2001. Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane. Diabetes 50: 1698-1705.
16. Duvivier-Kali VF, Omer A, Lopez-Avalos MD, O'Neil JJ, Weir GC. 2004. Survival of microencapsulated adult pig islets in mice in spite of an antibody response. Am J Transplant 4: 1991-2000.
17. Echeverri GJ, McGrath K, Bottino R, Hara H, Dons EM, van der Windt DJ, Ekser B, Casu A, Houser S, Ezzelarab M, et al. 2009. Endoscopic gastric submucosal transplantation of islets (ENDO-STI): Technique and initial results in diabetic pigs. Am J Transplant 9: 2485-2496.
18. Eich T, Eriksson O, Lundgren T. 2007a. Visualization of early engraftment in clinical islet transplantation by positron-emission tomography. N Engl J Med 356: 2754-2755.
19. Eich T, Eriksson O, Sundin A, Estrada S, Brandhorst D, Brandhorst H, Langstrom B, Nilsson B, Korsgren O, Lundgren T. 2007b. Positron emission tomography: A real-time tool to quantify early islet engraftment in a preclinical large animal model. Transplantation 84: 893-898.
20. Elliott RB, Escobar L, Tan PL, Muzina M, Zwain S, Buchanan C. 2007. Live encapsulated porcine islets from a type 1 diabetic patient 9. 5 yr after xenotransplantation. Xenotransplantation 14: 157-161.
21. Emamaullee JA, Rajotte RV, Liston P, Korneluk RG, Lakey JR, Shapiro AM, ElliottJF. 2005. XIAP overexpression in human islets prevents early posttransplant apoptosis and reduces the islet mass needed to treat diabetes. Diabetes 54: 2541-2548.
22. Eriksson O, Alavi A. 2011. Imaging the islet graft by positron emission tomography. Eur J Nucl Med Mol Imaging 39: 533-542.
23. Eriksson O, Eich T, Sundin A, Tibell A, Tufveson G, Andersson H, Felldin M, Foss A, Kyllonen L, Langstrom B, et al. 2009. Positron emission tomography in clinical islet transplantation. Am J Transplant 9: 2816-2824.
24. Faradji RN, Tharavanij T, Messinger S, Froud T, Pileggi A, Monroy K, Mineo D, Baidal DA, Cure P, Ponte G, et al. 2008. Long-term insulin independence and improvement in insulin secretion after supplemental islet infusion under exenatide and etanercept. Transplantation 86: 1658-1665.
25. Farney AC, Xenos E, Sutherland DE, Widmer M, Stephanian E, Field MJ, KaufmanDB, Stevens RB, Blazar B, Platt J, et al. 1993. Inhibition of pancreatic islet β cell function by tumor necrosis factor is blocked by a soluble tumor necrosis factor receptor. Transplant Proc 25: 865-866.
26. Froud T, Ricordi C, Baidal DA, Hafiz MM, Ponte G, Cure P, Pileggi A, Poggioli R, Ichii H, Khan A, et al. 2005. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant 5: 2037-2046.
27. Froud T, Baidal DA, Ponte G, Ferreira JV, Ricordi C, Alejandro R. 2006. Resolution of neurotoxicity and β-cell toxicity in an islet transplant recipient following substitution of tacrolimus with MMF. Cell Transplant 15: 613-620.
28. Gangemi A, Salehi P, Hatipoglu B, Martellotto J, Barbaro B, Kuechle JB, Qi M, Wang Y, Pallan P, Owens C, et al. 2008. Islet transplantation for brittle type 1 diabetes: The UIC protocol. Am J Transplant 8: 1250-1261.
29. Ghofaili KA, Fung M, Ao Z, Meloche M, Shapiro RJ, Warnock GL, Elahi D, Meneilly GS, Thompson DM. 2007. Effect of exenatide on β cell function after islet transplantation in type 1 diabetes. Transplantation 83: 24-28.
30. Han D, Xu X, Pastori RL, Ricordi C, Kenyon NS. 2002. Elevation of cytotoxic lymphocyte gene expression is predictive of islet allograft rejection in nonhuman primates. Diabetes 51: 562-566.
31. Han D, Xu X, Baidal D, Leith J, Ricordi C, Alejandro R, Kenyon NS. 2004. Assessment of cytotoxic lymphocyte gene expression in the peripheral blood of human islet allograft recipients: Elevation precedes clinical evidence of rejection. Diabetes 53: 2281-2290.
32. Hering BJ, Kandaswamy R, Harmon JV, Ansite JD, Clemmings SM, Sakai T, Paraskevas S, Eckman PM, Sageshima J, Nakano M, et al. 2004. Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody. Am J Transplant 4: 390-401.
33. Hering BJ, Kandaswamy R, Ansite JD, Eckman PM, Nakano M, Sawada T, Matsumoto I, Ihm SH, Zhang HJ, Parkey J, et al. 2005. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 293: 830-835.
34. Huurman VA, Hilbrands R, Pinkse GG, Gillard P, Duinkerken G, van de Linde P, van der Meer-Prins PM, Versteeg-van der Voort Maarschalk MF, Verbeeck K, Alizadeh BZ, et al. 2008. Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation. PLoS ONE 3: e2435.
35. Huurman VA, Velthuis JH, Hilbrands R, Tree TI, Gillard P, van der Meer-PrinsPM, Duinkerken G, Pinkse GG, Keymeulen B, Roelen DL, et al. 2009. Allograft-specific cytokine profiles associate with clinical outcome after islet cell transplantation. Am J Transplant 9: 382-388.
36. Johansson H, Lukinius A, Moberg L, Lundgren T, Berne C, Foss A, Felldin M, Kallen R, Salmela K, Tibell A, et al. 2005. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes 54: 1755-1762.
37. Johansson H, Goto M, Dufrane D, Siegbahn A, Elgue G, Gianello P, Korsgren O, Nilsson B. 2006. Low molecular weight dextran sulfate: A strong candidate drug to block IBMIR in clinical islet transplantation. Am J Transplant 6: 305-312.
38. Kin T, Johnson PR, Shapiro AM, Lakey JR. 2007. Factors influencing the collagenase digestion phase of human islet isolation. Transplantation 83: 7-12.
39. Kin T, Zhai X, O'Gorman D, Shapiro AM. 2008. Detrimental effect of excessive collagenase class II on human islet isolation outcome. Transpl Int 21: 1059-1065.
40. Koh A, Senior P, Salam A, Kin T, Imes S, Dinyari P, Malcolm A, Toso C, NilssonB, Korsgren O, et al. 2010. Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplant success. Transplantation 89: 465-471.
41. Lake SP, Bassett PD, Larkins A, Revell J, Walczak K, Chamberlain J, RumfordGM, London NJ, Veitch PS, Bell PR, et al. 1989. Large-scale purification of human islets utilizing discontinuous albumin gradient on IBM 2991 cell separator. Diabetes 38: 143-145.
42. Markmann JF, Deng S, Desai NM, Huang X, Velidedeoglu E, Frank A, Liu C, Brayman KL, Lian MM, Wolf B, et al. 2003. The use of non-heart-beating donors for isolated pancreatic islet transplantation. Transplantation 75: 1423-1429.
43. Matsumoto I, Sawada T, Nakano M, Sakai T, Liu B, Ansite JD, Zhang HJ, Kandaswamy R, Sutherland DE, Hering BJ. 2004. Improvement in islet yield from obese donors for human islet transplants. Transplantation 78: 880-885.
44. Matsumoto S, Okitsu T, Iwanaga Y, Noguchi H, Nagata H, Yonekawa Y, Yamada Y, Fukuda K, Tsukiyama K, Suzuki H, et al. 2005. Insulin independence after living-donor distal pancreatectomy and islet allotransplantation. Lancet 365: 1642-1644.
45. Matsumoto S, Takita M, Chaussabel D, Noguchi H, Shimoda M, Sugimoto K, Itoh T, Chujo D, Sorelle J, Onaca N, et al. 2011. Improving efficacy of clinical islet transplantation with iodixanol based islet purification, thymoglobulin induction and blockage of IL-1-β and TNF-α. Cell Transplant 20: 1641-1647.
46. McCall M, Pawlick R, Kin T, Shapiro AM. 2011a. Anakinra potentiates the protective effects of etanercept in transplantation of marginal mass human islets in immunodeficient mice. Am J Transplant 12: 322-329.
47. McCall M, Toso C, Emamaullee J, Pawlick R, Edgar R, Davis J, Maciver A, Kin T, Arch R, Shapiro AM. 2011b. The caspase inhibitor IDN-6556 (PF3491390) improves marginal mass engraftment after islet transplantation in mice. Surgery 150: 48-55.
48. Medarova Z, Moore A. 2009. MRI as a tool to monitor islet transplantation. Nat Rev Endocrinol 5: 444-452.
49. Mehigan DG, Bell WR, Zuidema GD, Eggleston JC, Cameron JL. 1980. Disseminated intravascular coagulation and portal hypertension following pancreatic islet autotransplantation. Ann Surg 191: 287-293.
50. Merani S, Toso C, Emamaullee J, Shapiro AMJ. 2008a. Optimal implantation site for pancreatic islet transplantation. Br J Surgery 95: 1449-1461.
51. Merani S, Truong W, Emamaullee JA, Toso C, Knudsen LB, Shapiro AM. 2008b. Liraglutide, a long-acting human glucagon-like peptide 1 analog, improves glucose homeostasis in marginal mass islet transplantation in mice. Endocrinology 149: 4322-4328.
52. Mertens M, Singh JA. 2009. Anakinra for rheumatoid arthritis. Cochrane Database Syst Rev CD005121.
53. Mita A, Ricordi C, Messinger S, Miki A, Misawa R, Barker S, Molano RD, Haertter R, Khan A, Miyagawa S, et al. 2010. Anti-proinflammatory effects of iodixanol (OptiPrep)-based density gradient purification on human islet preparations. Cell Transplant 19: 1537-1546.
54. Mittal VK, Toledo-Pereyra LH, Sharma M, Ramaswamy K, Puri VK, Cortez JA, Gordon D. 1981. Acute portal hypertension and disseminated intravascular coagulation following pancreatic islet autotransplantation after subtotal pancreatectomy. Transplantation 31: 302-304.
55. Morel P, Kaufman DB, Field MJ, Lloveras JK, Matas AJ, Sutherland DE. 1992. Detrimental effect of prednisone on canine islet autograft function. Transplant Proc 24: 1048-1050.
56. Nano R, Clissi B, Melzi R, Calori G, Maffi P, Antonioli B, Marzorati S, AldrighettiL, Freschi M, Grochowiecki T, et al. 2005. Islet isolation for allotransplantation: Variables associated with successful islet yield and graft function. Diabetologia 48: 906-912.
57. Nepom GT. 2005. Tetramer analysis of human autoreactive CD4-positive T cells. Adv Immunol 88: 51-71.
58. Nilsson B, Ekdahl KN, Korsgren O. 2011. Control of instant blood-mediated inflammatory reaction to improve islets of Langerhans engraftment. Curr Opin Organ Transplant 16: 620-626.
59. Noguchi H, Ikemoto T, Naziruddin B, Jackson A, Shimoda M, Fujita Y, Chujo D, Takita M, Kobayashi N, Onaca N, et al. 2009. Iodixanol-controlled density gradient during islet purification improves recovery rate in human islet isolation. Transplantation 87: 1629-1635.
60. O'Gorman D, Kin T, Murdoch T, Richer B, McGhee-Wilson D, Ryan EA, ShapiroJA, Lakey JR. 2005. The standardization of pancreatic donors for islet isolations. Transplantation 80: 801-806.
61. O'Gorman D, Kin T, Imes S, Pawlick R, Senior P, Shapiro AM. 2010. Comparison of human islet isolation outcomes using a new mammalian tissue-free enzyme versus collagenase NB-1. Transplantation 90: 255-259.
62. Omer A, Duvivier-Kali VF, Trivedi N, Wilmot K, Bonner-Weir S, Weir GC. 2003. Survival and maturation of microencapsulated porcine neonatal pancreatic cell clusters transplanted into immunocompetent diabetic mice. Diabetes 52: 69-75.
63. Owen RJ, Ryan EA, O'Kelly K, Lakey JR, McCarthy MC, Paty BW, Bigam DL, Kneteman NM, Korbutt GS, Rajotte RV, et al. 2003. Percutaneous transhepatic pancreatic islet cell transplantation in type 1 diabetes mellitus: Radiologic aspects. Radiology 229: 165-170.
64. Pedersen-Bjergaard U, Pramming S, Heller SR, Wallace TM, Rasmussen AK, Jorgensen HV, Matthews DR, Hougaard P, Thorsteinsson B. 2004. Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: Influence of risk markers and selection. Diabetes Metab Res Rev 20: 479-486.
65. Posselt AM, Bellin MD, Tavakol M, Szot GL, Frassetto LA, Masharani U, KerlanRK, Fong L, Vincenti FG, Hering BJ, et al. 2010a. Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab. Am J Transplant 10: 1870-1880.
66. Posselt AM, Szot GL, Frassetto LA, Masharani U, Tavakol M, Amin R, McElroy J, Ramos MD, Kerlan RK, Fong L, et al. 2010b. Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade. Transplantation 90: 1595-1601.
67. Pugliese A, Reijonen HK, Nepom J, Burke GW III. 2011. Recurrence of autoimmunity in pancreas transplant patients: Research update. Diabetes Manag (Lond) 1: 229-238.
68. Rafael E, Tibell A, Ryden M, Lundgren T, Savendahl L, Borgstrom B, Arnelo U, Isaksson B, Nilsson B, Korsgren O, et al. 2008. Intramuscular autotransplantation of pancreatic islets in a 7-year-old child: A 2-year follow-up. Am J Transplant 8: 458-462.
69. Ricordi C, Lacy PE, Scharp DW. 1989. Automated islet isolation from human pancreas. Diabetes 38: 140-142.
70. Rossini AA. 2004. Autoimmune diabetes and the circle of tolerance. Diabetes 53: 267-275.
71. Saidi RF, Bradley J, Greer D, Luskin R, O'Connor K, Delmonico F, Kennealey P, Pathan F, Schuetz C, Elias N, et al. 2010. Changing pattern of organ donation at a single center: Are potential brain dead donors being lost to donation after cardiac death? Am J Transplant 10: 2536-2540.
72. Scharp DW, Lacy PE, Santiago JV, McCullough CS, Weide LG, Falqui L, MarchettiP, Gingerich RL, Jaffe AS, Cryer PE, et al. 1990. Insulin independence after islet transplantation into type I diabetic patient. Diabetes 39: 515-518.
73. Scharp DW, Swanson CJ, Olack BJ, Latta PP, Hegre OD, Doherty EJ, Gentile FT, Flavin KS, Ansara MF, Lacy PE. 1994. Protection of encapsulated human islets implanted without immunosuppression in patients with type I or type II diabetes and in nondiabetic control subjects. Diabetes 43: 1167-1170.
74. Shapiro AM, Hao E, Lakey JR, Finegood D, Rajotte RV, Kneteman NM. 1998. Diabetogenic synergism in canine islet autografts from cyclosporine and steroids in combination. Transplant Proc 30: 527.
75. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV. 2000. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343: 230-238.
76. Shapiro AM, Ricordi C, Hering B. 2003. Edmonton's islet success has indeed been replicated elsewhere. Lancet 362: 1242.
77. Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, Secchi A, Brendel MD, Berney T, Brennan DC, et al. 2006. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 355: 1318-1330.
78. Sharma V, Andersen D, Thompson M, Woda BA, Stoff JS, Hartigan C, RastelliniC, Phillips D, Mordes JP, Rossini AA. 2006. Autoimmunity after islet-cell allotransplantation. N Engl J Med 355: 1397-1399.
79. Suzuki K, Bonner-Weir S, Trivedi N, Yoon KH, Hollister-Lock J, Colton CK, WeirGC. 1998. Function and survival of macroencapsulated syngeneic islets transplanted into streptozocin-diabetic mice. Transplantation 66: 21-28.
80. Szot GL, Lee MR, Tavakol MM, Lang J, Dekovic F, Kerlan RK, Stock PG, PosseltAM. 2009. Successful clinical islet isolation using a GMP-manufactured collagenase and neutral protease. Transplantation 88: 753-756.
81. The Collaborative Islet Transplant Registry. 2009. Annual Report, www. citregistryorg/reports/reports. htm.
82. Thompson DM, Meloche M, Ao Z, Paty B, Keown P, Shapiro RJ, Ho S, Worsley D, Fung M, Meneilly G, et al. 2011. Reduced progression of diabetic microvascular complications with islet cell transplantation compared with intensive medical therapy. Transplantation 91: 373-378.
83. Toronto Congenital Cardiac Centre for Adults (TCCCA) Team. 2009. The Collaborative Islet Transplant Registry 2009 Annual Report, www. citregistryorg/reports/reports. htm.
84. Toso C, Vallee JP, Morel P, Ris F, Demuylder-Mischler S, Lepetit-Coiffe M, Marangon N, Saudek F, James Shapiro AM, Bosco D, et al. 2008. Clinical magnetic resonance imaging of pancreatic islet grafts after iron nanoparticle labeling. Am J Transplant 8: 701-706.
85. Toso C, Isse K, Demetris AJ, Dinyari P, Koh A, Imes S, Kin T, Emamaullee J, Senior P, Shapiro AM. 2009. Histologic graft assessment after clinical islet transplantation. Transplantation 88: 1286-1293.
86. Toso C, McCall M, Emamaullee J, Merani S, Davis J, Edgar R, Pawlick R, Kin T, Knudsen LB, Shapiro AM. 2010. Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in culture. Transpl Int 23: 259-265.
87. Vaithilingam V, Tuch BE. 2011. Islet transplantation and encapsulation: An update on recent developments. Rev Diabet Stud 8: 51-67.
88. Vendrame F, Pileggi A, Laughlin E, Allende G, Martin-Pagola A, Molano RD, Diamantopoulos S, Standifer N, Geubtner K, Falk BA, et al. 2010. Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells. Diabetes 59: 947-957.
89. Villiger P, Ryan EA, Owen R, O'Kelly K, Oberholzer J, Al Saif F, Kin T, Wang H, Larsen I, Blitz SL, et al. 2005. Prevention of bleeding after islet transplantation: Lessons learned from a multivariate analysis of 132 cases at a single institution. Am J Transplant 5: 2992-2998.
90. Vincenti F, Larsen C, Durrbach A, Wekerle T, Nashan B, Blancho G, Lang P, Grinyo J, Halloran PF, Solez K, et al. 2005. Costimulation blockade with belatacept in renal transplantation. N Engl J Med 353: 770-781.
91. Warnock GL, Thompson DM, Meloche RM, Shapiro RJ, Ao Z, Keown P, JohnsonJD, Verchere CB, Partovi N, Begg IS, et al. 2008. A multi-year analysis of islet transplantation compared with intensive medical therapy on progression of complications in type 1 diabetes. Transplantation 86: 1762-1766.
92. Williams PW. 1894. Notes on diabetes treated with extract and by grafts of sheep's pancreas. Br Med J: 1303-1304.
93. Witkowski P, Liu Z, Cernea S, Guo Q, Poumian-Ruiz E, Herold K, Hardy MA. 2006. Validation of the scoring system for standardization of the pancreatic donor for islet isolation as used in a new islet isolation center. Transplant Proc 38: 3039-3040.
94. Wszola M, Berman A, Fabisiak M, Domagala P, Zmudzka M, Kieszek R, Perkowska-Ptasinska A, Sabat M, Pawelec K, Kownacki L, et al. 2009. TransEndoscopic Gastric SubMucosa Islet Transplantation (eGSM-ITx) in pigs with streptozotocine induced diabetes-Technical aspects of the procedure-Preliminary report. Ann Transplant 14: 45-50.
95. Yang Z, Chen M, Fialkow LB, Ellett JD, Wu R, Nadler JL. 2002. Survival of pancreatic islet xenografts in NOD mice with the theracyte device. Transplant Proc 34: 3349-3350.
96. Zeng Y, Torre MA, Karrison T, Thistlethwaite JR. 1994. The correlation between donor characteristics and the success of human islet isolation. Transplantation 57: 954-958.